June 23, 2023
June 23, 2023 -
Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved Litfulo (ritlecitinib), a once-daily oral treatment
June 22, 2023
June 22, 2023 -
Sebela Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA)
granted approval of Suflave TM
June 22, 2023
June 22, 2023 –
Sarepta Therapeutics, Inc., announced U.S. Food and Drug Administration (FDA)
accelerated approval of Elevidys (delandistrogene moxeparvovec-rokl)
June 21, 2023
June 21, 2023 -
Amgen announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application
June 20, 2023
June 20, 2023 -
AGEPHA Pharma USA, LLC, has announced that, following a Priority Review, the U.S. Food and Drug Administration (FDA) has approved Lodoco®
June 20, 2023
June 20, 2023 -
Halozyme Therapeutics, Inc. has announced that argenx received U.S. Food and Drug Administration (FDA) approval for Vyvgart® Hytrulo
June 15, 2023
June 15, 2023 -
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved Columvi
June 13, 2023
June 13, 2023 -
The Harvard Drug Group, LLC and Rugby Laboratories has initiated a voluntary recall of a
single lot of Dronabinol Capsules